Veru, Inc. (VERU)
2.80
+0.18
(+6.67%)
USD |
NASDAQ |
Aug 31, 16:00
2.79
-0.01
(-0.36%)
After-Hours: 20:00
Veru Cash from Operations (TTM) : -26.04M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.04M |
| March 31, 2026 | -26.06M |
| December 31, 2025 | -24.88M |
| September 30, 2025 | -30.04M |
| June 30, 2025 | -28.92M |
| March 31, 2025 | -29.08M |
| December 31, 2024 | -26.99M |
| September 30, 2024 | -21.68M |
| June 30, 2024 | -26.81M |
| March 31, 2024 | -39.59M |
| December 31, 2023 | -59.50M |
| September 30, 2023 | -88.01M |
| June 30, 2023 | -99.40M |
| March 31, 2023 | -94.99M |
| December 31, 2022 | -73.38M |
| September 30, 2022 | -47.50M |
| June 30, 2022 | -27.43M |
| March 31, 2022 | -26.25M |
| December 31, 2021 | -24.89M |
| September 30, 2021 | -15.57M |
| June 30, 2021 | -15.11M |
| March 31, 2021 | 1.067M |
| December 31, 2020 | 1.240M |
| September 30, 2020 | -1.930M |
| June 30, 2020 | -2.544M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.410M |
| December 31, 2019 | -6.489M |
| September 30, 2019 | -5.485M |
| June 30, 2019 | -7.345M |
| March 31, 2019 | -11.25M |
| December 31, 2018 | -13.35M |
| September 30, 2018 | -11.55M |
| June 30, 2018 | -8.154M |
| March 31, 2018 | -2.260M |
| December 31, 2017 | 0.1136M |
| September 30, 2017 | 0.9829M |
| June 30, 2017 | -0.4172M |
| March 31, 2017 | -1.463M |
| December 31, 2016 | -0.1172M |
| September 30, 2016 | -1.714M |
| June 30, 2016 | 0.5972M |
| March 31, 2016 | -0.0311M |
| December 31, 2015 | -0.7598M |
| September 30, 2015 | -1.549M |
| June 30, 2015 | -0.8533M |
| March 31, 2015 | -0.3297M |
| December 31, 2014 | 1.264M |
| September 30, 2014 | 3.665M |
| June 30, 2014 | 0.5175M |
| March 31, 2014 | 7.967M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |
| Lexicon Pharmaceuticals, Inc. | -64.99M |